… encephalitis like primary measles encephalitis and acute post infectious measles
encephalomyelitis or it … The newer therapeutic options are based on these mutations and are …

… to use in PEP, a measles therapeutic may be beneficial for … measles [44,45], SSPE typically
occurs years after measles … from rapid advance to chronic encephalitis. Approximately 95% of …

… Encephalitis may either follow an acute course (primary measles encephalitis and acute
encephalitis… Chronic presentation is further subdivided into measles inclusion body encephalitis …

… potential challenge for using MeV especially for systemic anti-tumor therapy. Because of the
availability of safe and effective measles vaccines since the 1960’s or the extraordinary high …

… measles is associated with a higher risk of complications such as pneumonia and encephalitis
… Here we have discussed the most reliable therapeutic approaches for diagnosed cases of …

… measles can occur within days or years of acute infection and are often severe. These include
primary measles encephalitis, acute postinfectious measles … No specific effective therapy …

… sclerosing pan-encephalitis which is a potentially fatal and serious complication of measles.
The … may not work as a therapeutic treatment or prevent encephalitis in this circumstance. …

… been used for this condition: “acute measles encephalitis associated with immunosuppression,”
“subacute measles virus encephalitis,” or “measles inclusionbody encephalitis” (MIBE). …

… therapeutic plasma exchange, the patient was successfully treated. This case provides a
new strategy for treating measles encephalitis and its complications during measles outbreak. …

… therapeutic … measles virus, a prime candidate for cancer immunovirotherapy. Furthermore,
we will provide a brief overview of measles virus-based multimodal combination therapies for …